Fig. 2From: Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancerSurvival analysis comparing patients in the normal group and patients in the abnormal group. Total population of the discovery cohort (a); total population of the validation cohort (b)Back to article page